The New England journal of medicine
-
Randomized Controlled Trial Clinical Trial
Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
Some patients with inflammatory bowel disease have anemia that is refractory to treatment with iron and vitamins. We examined whether administering iron and recombinant erythropoietin could raise hemoglobin levels in such patients. ⋯ In patients with inflammatory bowel disease and anemia refractory to treatment with iron and vitamins, treatment with oral iron and recombinant erythropoietin can raise hemoglobin levels.